reason smile solid org sale acceler
lift estimate pt
rais ep pt cl solid maintain
guidanc recoveri china take time cl importantli see progress
across key market incl us lat colgat total relaunch
progress in-lin expect top-line recoveri encourag p/
 cl share return hist average premium hpc group
limit stock hold
clean continu trend organ sale upsid hpc
themat us hpc cl like pg/kmb deliv upsid org sale vs
modest demand elast recent price anticip put take
gm miss sg beat deliv rel clean ep upsid vs
result put cl path achiev org sale guidanc comp eas
though believ take meaning improv em biz sale
grew quarter compani deliv result ahead peer
reiter guidanc competit spend hpc remain risk
cl reiter guid call org sale ii mid-single-digit ep declin owe
larg stepped-up invest bp yoy lower
bp previous anticip support innov expect seem reason
midpoint cl rang street market appear focus
top-line acceler though continu monitor risk hpc increas
spend could limit ep upsid see note hey spender
invest risk global hpc ulvr pg rb expos link
takeaway confer call
categori growth global categori posit cl well achiev org sale
guidanc em improv dm flat us tick europ
sideway ii colgat total re-launch proceed plan market share
yoy strong competit respons na flat share toothpast cl chase
share cost iii em brazil saw price volum growth categori trend
seem better china still expect improv india strong
iv price still implement price stuck everywher colgat total
re-launch
rais ep estim pt maintain hold rate
rais ep estim cl clean quarter in-line/reiter
guidanc ntm price-to-earnings share return histor averag premium
hpc peer despit result arguabl pedestrian past
updat pt impli share trade though believ upsid valuat
limit bar greater visibl margin improv em acceler
reiter hold rate better opportun group top pick chd/enr
hpc
pleas see analyst certif import disclosur inform inform regard statu non-u analyst
page report
colgat view potenti target larg cpg
colgat oral care franchis among best busi
cpg market share growth margin perspect
cl lever among coverag recoveri
organ sale growth
oper margin declin bp bp
expans
ep lower due step invest
normal
price target ev/ebitda ntm
ebitda ev/ulfcf ulfcf
bp top-line volum upsid rebound emerg
bp oper margin upsid increment
product potenti commod tailwind
price target ev/ebitda ntm
ebitda ev/ulfcf ulfcf
bp top-line volum downsid emerg market
bp margin pressur increas trade promot
unfavor move commod
price target ev/ebitda ntm
ebitda ev/ulfcf ulfcf
pleas see import disclosur inform page report
financi summari market data
estim valuat
pleas see import disclosur inform page report
cl deliv gener clean beat
street modest gross margin miss
lower sg drove slight ep beat
cl maintain guidanc includ
organ sale growth mid-single-
digit ep declin mid-point
in-lin street
sale flat low-single-digit net sale growth organ sale growth
reiter
gross margin bp expans reiter expans yoy
raw materi basket increas yoy updat
advertis expect around rate
pleas see import disclosur inform page report
actualjef estimate million except incom expens incom compositionreport org sale bpsfx bp sale bpsmargin analysisgross bpsoper bpsebitda bpstax bp equiti research
colgat thesi chart
chart near-term macro competit pressur em
like keep cl org sale growth well histor
chart compani face materi moder vs best-
in-class growth
chart expect cl oi growth remain pressur
near-to-intermedi term well growth
chart colgat margin enhanc impress
still expect slower growth due constrain top-line
commod fx invest
chart despit higher margin/fcf profil vs stapl cl
top-line pressur weigh stock multipl
chart cl valuat emb littl strateg halo busi
stall news report potenti suitor last report
quiet front
pleas see import disclosur inform page report
develop market growth market growth organ sale growth em/dm em/dm org sale growth em org sale growthdm org sale growthtot sale growth fx neutral oi growthorg sale growthfx neutral oi margin ebitda marginebitda right axi gm left salesgrowthebitda conversionul p/ecl vs peer -key metricsclstapl peer ntm ev/ebitda vs peer nielsen result period end
chart cl four-week quarterli sale growth
nielsen xaoc jefferi note nielsen definit may differ compani defin
pleas see import disclosur inform page report
quarterli sale growth sale growth yoy sale growthtwo-year averag sale growthxaoc ccolgat palmol mixlatest soap-light cleaners-multi sale chg vs yageq sale chg vs yagavg eq price chg vs yagdollar share pt chg vs yageq share pt chg vs yag sold promo pt chg vs yag us market share dashboard
chart colgat sale growth vs industri growth left portfolio gain market share right
pleas see import disclosur inform page report
us track channel growth vs industri weight industri growthcl sale portfolio gain valu share trail averagetrail ltm averag chart consum stapl group ev/unlev multipl
factset jefferi note factset consensu estim use non-cov compani
factset jefferi note factset consensu estim use non-cov compani
factset jefferi note factset consensu estim use non-cov compani
pleas see import disclosur inform page report
factset jefferi note factset consensu estim use non-cov compani
pleas see import disclosur inform page report
cl trade near long-term averag vs hpc
chart cl histor ntm price-to-earnings multipl vs
pleas see import disclosur inform page report
